Cancer immunotherapies targeting the PD-1 signaling pathway

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1423-0127

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Cancer immunotherapies targeting the PD-1 signaling pathway ; volume:24 ; number:1 ; day:4 ; month:4 ; year:2017 ; pages:1-11 ; date:12.2017
Journal of biomedical science ; 24, Heft 1 (4.4.2017), 1-11, 12.2017

Keyword: Krebs
Onkologie

Creator: Iwai, Yoshiko

Contributor: Hamanishi, Junzo
Chamoto, Kenji
Honjo, Tasuku
SpringerLink (Online service)

DOI: 10.1186/s12929-017-0329-9

URN: urn:nbn:de:1111-201704224030

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Iwai, Yoshiko
Hamanishi, Junzo
Chamoto, Kenji
Honjo, Tasuku
SpringerLink (Online service)

Other Objects (12)

Immunotherapies targeting stimulatory pathways and beyond

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling

Targeting the PDGF signaling pathway in tumor treatment

Buformin suppresses osteosarcoma via targeting AMPK signaling pathway

Targeting the Wnt/β-catenin signaling pathway in cancer

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Natural products targeting the MAPK-signaling pathway in cancer: overview

γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway

Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway

Aufsatzsammlung

Immunotherapies in solid tumors

Immunotherapies in rare cancers

Immunotherapies targeting stimulatory pathways and beyond

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling

Targeting the PDGF signaling pathway in tumor treatment

Buformin suppresses osteosarcoma via targeting AMPK signaling pathway

Targeting the Wnt/β-catenin signaling pathway in cancer

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Natural products targeting the MAPK-signaling pathway in cancer: overview

γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway

Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway

Aufsatzsammlung

Immunotherapies in solid tumors

Immunotherapies in rare cancers

Immunotherapies targeting stimulatory pathways and beyond

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling

Targeting the PDGF signaling pathway in tumor treatment

Buformin suppresses osteosarcoma via targeting AMPK signaling pathway

Targeting the Wnt/β-catenin signaling pathway in cancer

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Natural products targeting the MAPK-signaling pathway in cancer: overview

γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway

Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway

Aufsatzsammlung

Immunotherapies in solid tumors

Immunotherapies in rare cancers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Cancer immunotherapies targeting the PD-1 signaling pathway

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Immunotherapies targeting stimulatory pathways and beyond

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling

Targeting the PDGF signaling pathway in tumor treatment

Buformin suppresses osteosarcoma via targeting AMPK signaling pathway

Targeting the Wnt/β-catenin signaling pathway in cancer

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Natural products targeting the MAPK-signaling pathway in cancer: overview

γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway

Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway

Immunotherapies in solid tumors

Immunotherapies in rare cancers

Immunotherapies targeting stimulatory pathways and beyond

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling

Targeting the PDGF signaling pathway in tumor treatment

Buformin suppresses osteosarcoma via targeting AMPK signaling pathway

Targeting the Wnt/β-catenin signaling pathway in cancer

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Natural products targeting the MAPK-signaling pathway in cancer: overview

γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway

Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway

Immunotherapies in solid tumors

Immunotherapies in rare cancers

Immunotherapies targeting stimulatory pathways and beyond

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling

Targeting the PDGF signaling pathway in tumor treatment

Buformin suppresses osteosarcoma via targeting AMPK signaling pathway

Targeting the Wnt/β-catenin signaling pathway in cancer

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Natural products targeting the MAPK-signaling pathway in cancer: overview

γ-tocotrienol regulates gastric cancer by targeting notch signaling pathway

Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway

Immunotherapies in solid tumors

Immunotherapies in rare cancers

Related objects

Reset password